# Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rifaximin-for-the-treatment-of-active-pouchitis-a-randomized-double-blind/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kim L. Isaacs,Robert S. Sandler,María T. Abreu,Michael F. Picco,Stephen B. Hanauer,Stephen J. Bickston,Daniel H. Present,Francis A. Farraye,Douglas C. Wolf,William J. Sandborn |
| Citations | 118 |
| DOI | 10.1002/ibd.20187 |
| Fields | Biochemistry, Genetics and Molecular Biology,Health Professions,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2083513339 |
| PMID | 17567869 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Michael F. Picco](https://scholariq.org/researchers/michael-f-picco/)

## Paper primary topic

- [Travel-related health issues](https://scholariq.org/topics/travel-related-health-issues/)

## Paper topics

- [Travel-related health issues](https://scholariq.org/topics/travel-related-health-issues/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)
- [Pediatric health and respiratory diseases](https://scholariq.org/topics/pediatric-health-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.